10 Although these data cannot be extrapolated to the brain and lung due to nuances in treatment, we see a clear trend among radiation oncologists in North America and Europe who have proven to be early adopters of hypofractionation and so may reap its advantages.
← all excerpts
Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia.
1
—
—